123 related articles for article (PubMed ID: 38258649)
41. Creatine mapping of the brain at 3T by CEST MRI.
Wang K; Huang J; Ju L; Xu S; Gullapalli RP; Liang Y; Rogers J; Li Y; van Zijl PCM; Weiss RG; Chan KWY; Xu J
Magn Reson Med; 2024 Jan; 91(1):51-60. PubMed ID: 37814487
[TBL] [Abstract][Full Text] [Related]
42. Dynamic alteration in myocardium creatine during acute infarction using MR CEST imaging.
Liu J; Xie CM; Liu Q; Xu J; Zheng LY; Liu X; Zheng H; Wu Y
NMR Biomed; 2022 Jul; 35(7):e4704. PubMed ID: 35102636
[TBL] [Abstract][Full Text] [Related]
43. B1+ inhomogeneity mitigation in CEST using parallel transmission.
Tse DHY; da Silva NA; Poser BA; Shah NJ
Magn Reson Med; 2017 Dec; 78(6):2216-2225. PubMed ID: 28244138
[TBL] [Abstract][Full Text] [Related]
44. A rapid method for phosphocreatine-weighted imaging in muscle using double saturation power-chemical exchange saturation transfer.
Viswanathan M; Kurmi Y; Zu Z
NMR Biomed; 2024 Apr; 37(4):e5089. PubMed ID: 38114069
[TBL] [Abstract][Full Text] [Related]
45. Chemical exchange saturation transfer of the cervical spinal cord at 7 T.
Dula AN; Pawate S; Dethrage LM; Conrad BN; Dewey BE; Barry RL; Smith SA
NMR Biomed; 2016 Sep; 29(9):1249-57. PubMed ID: 27459342
[TBL] [Abstract][Full Text] [Related]
46. Creatine and phosphocreatine mapping of mouse skeletal muscle by a polynomial and Lorentzian line-shape fitting CEST method.
Chen L; Barker PB; Weiss RG; van Zijl PCM; Xu J
Magn Reson Med; 2019 Jan; 81(1):69-78. PubMed ID: 30246265
[TBL] [Abstract][Full Text] [Related]
47. Global deep learning optimization of chemical exchange saturation transfer magnetic resonance fingerprinting acquisition schedule.
Cohen O; Otazo R
NMR Biomed; 2023 Oct; 36(10):e4954. PubMed ID: 37070221
[TBL] [Abstract][Full Text] [Related]
48. Downfield-NOE-suppressed amide-CEST-MRI at 7 Tesla provides a unique contrast in human glioblastoma.
Zaiss M; Windschuh J; Goerke S; Paech D; Meissner JE; Burth S; Kickingereder P; Wick W; Bendszus M; Schlemmer HP; Ladd ME; Bachert P; Radbruch A
Magn Reson Med; 2017 Jan; 77(1):196-208. PubMed ID: 26845067
[TBL] [Abstract][Full Text] [Related]
49. Amide proton transfer imaging of glioblastoma, neuroblastoma, and breast cancer cells on a 11.7 T magnetic resonance imaging system.
Tanoue M; Saito S; Takahashi Y; Araki R; Hashido T; Kioka H; Sakata Y; Yoshioka Y
Magn Reson Imaging; 2019 Oct; 62():181-190. PubMed ID: 31302222
[TBL] [Abstract][Full Text] [Related]
50. Characterization of amine proton exchange for analyzing the specificity and intensity of the CEST effect: from humans to fish.
Wermter FC; Bock C; Dreher W
NMR Biomed; 2022 Feb; 35(2):e4622. PubMed ID: 34605080
[TBL] [Abstract][Full Text] [Related]
51. Generalization of quasi-steady-state reconstruction to CEST MRI with two-tiered RF saturation and gradient-echo readout-Synergistic nuclear Overhauser enhancement contribution to brain tumor amide proton transfer-weighted MRI.
Sun PZ
Magn Reson Med; 2023 May; 89(5):2014-2023. PubMed ID: 36579767
[TBL] [Abstract][Full Text] [Related]
52. Combining chemical exchange saturation transfer and
Hoefemann M; Döring A; Fichtner ND; Kreis R
Magn Reson Med; 2021 Apr; 85(4):1766-1782. PubMed ID: 33151011
[TBL] [Abstract][Full Text] [Related]
53. A Pilot Study of Ratiometric Creatine CEST MRI Assessment of Rabbit Skeletal Muscle Energy Metabolism at 3 T.
Zhao J; Wu G; Wu Q; Gong P; Kuang J; Zheng H; Sun PZ; Li Y; Wu Y
J Magn Reson Imaging; 2024 Jan; 59(1):201-208. PubMed ID: 37246769
[TBL] [Abstract][Full Text] [Related]
54. Optimization of 7-T chemical exchange saturation transfer parameters for validation of glycosaminoglycan and amide proton transfer of fibroglandular breast tissue.
Dula AN; Dewey BE; Arlinghaus LR; Williams JM; Klomp D; Yankeelov TE; Smith S
Radiology; 2015 Apr; 275(1):255-61. PubMed ID: 25353249
[TBL] [Abstract][Full Text] [Related]
55. Evaluating the Cisplatin Dose Dependence of Testicular Dysfunction Using Creatine Chemical Exchange Saturation Transfer Imaging.
Sawaya R; Kuribayashi S; Ueda J; Saito S
Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626202
[TBL] [Abstract][Full Text] [Related]
56. Angiopep-2 as an Exogenous Chemical Exchange Saturation Transfer Contrast Agent in Diagnosis of Alzheimer's Disease.
Wang C; Lin G; Shen Z; Wang R
J Healthc Eng; 2022; 2022():7480519. PubMed ID: 35422975
[TBL] [Abstract][Full Text] [Related]
57. Multiple CEST contrast imaging of nose-to-brain drug delivery using iohexol liposomes at 3T MRI.
Law LH; Huang J; Xiao P; Liu Y; Chen Z; Lai JHC; Han X; Cheng GWY; Tse KH; Chan KWY
J Control Release; 2023 Feb; 354():208-220. PubMed ID: 36623695
[TBL] [Abstract][Full Text] [Related]
58. Distinction of the GABA 2.29 ppm resonance using triple refocusing at 3 T in vivo.
Tiwari V; An Z; Wang Y; Choi C
Magn Reson Med; 2018 Oct; 80(4):1307-1319. PubMed ID: 29446149
[TBL] [Abstract][Full Text] [Related]
59. Glutamic Acid and Total Creatine as Predictive Markers for Epilepsy in Glioblastoma by Using Magnetic Resonance Spectroscopy Before Surgery.
Hashiguchi M; Tanaka K; Nagashima H; Fujita Y; Tanaka H; Kohta M; Nakai T; Uozumi Y; Maeyama M; Somiya Y; Kohmura E; Sasayama T
World Neurosurg; 2022 Apr; 160():e501-e510. PubMed ID: 35077889
[TBL] [Abstract][Full Text] [Related]
60. Characterization of creatine guanidinium proton exchange by water-exchange (WEX) spectroscopy for absolute-pH CEST imaging in vitro.
Goerke S; Zaiss M; Bachert P
NMR Biomed; 2014 May; 27(5):507-18. PubMed ID: 24535718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
